Results 221 to 230 of about 386,873 (322)
The management of cancer and tissue regeneration remains a substantial challenge to global health. Organoids, which are stem cell‐derived three‐dimensional multicellular structures, are revolutionizing biomedical research. Therefore, this review highlights their applications in cancer research and regenerative medicine, while discussing current ...
Ruiyang Li +5 more
wiley +1 more source
Comparative Outcomes of Neo-Adjuvant Chemo-Radiotherapy in Stage II and III Mucinous versus Non-Mucinous Rectal Adenocarcinoma: A Retrospective Study. [PDF]
Al-Kubati WR.
europepmc +1 more source
KRAS and NKX2‐1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung
D. Hwang +11 more
semanticscholar +1 more source
This study utilizes whole‐genome sequencing of 197 paired samples to conduct mutational profiling of colorectal cancer (CRC) in Korean patients, identifying novel driver genes associated with recurrence. The research provides insights into oncogenic pathways and highlights clinically significant variants, emphasizing the importance of ethnic diversity ...
Junho Kang +29 more
wiley +1 more source
Clinicopathological features and prognosis of patients with colorectal Mucinous adenocarcinoma mixed with other pathological components: a nationwide retrospective study in China. [PDF]
Yuan J +27 more
europepmc +1 more source
A Case of Canine Gallbladder Mucocele With Intramural Haematoma and Rupture
A 10‐year‐old, neutered male, Poodle mix presented for evaluation of anorexia, vomiting and elevated liver enzymes. The patient underwent emergent cholecystectomy for suspicion of a ruptured gallbladder mucocele with a possible concurrent mass effect within the gallbladder.
Kira H. Lin, Whitney Zoll, Morgan Biggo
wiley +1 more source
Clinical Benefits of KRAS/GNAS Gene Mutation Analysis in Addition to Morphology and Conventional Cyst Fluid Testing in Differentiating Pancreatic Cysts. [PDF]
Gyimesi G +11 more
europepmc +1 more source
Question: What is the efficacy of adjuvant therapy in resected invasive IPMN? Findings: This meta‐analysis showed that patients with invasive IPMN do not benefit from adjuvant therapy (HR 1.21, 95% IC: 0.81−1.79). A subgroup analysis showed that node‐positive patients have an improved OS (HR 1.86; 95% CI 1.39; 2.47, p < 0.001).
Carlo Ingaldi +9 more
wiley +1 more source

